Back to Search
CLARISSA GEYER, M.D.
M.D.
Hematology & Oncology Physician
NPI: 1528264223IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
MD0000034568(TN)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1989
Research & Publications (20)
Prognosis after ipsilateral breast tumor recurrence and locoregional recurrences in patients treated by breast-conserving therapy in five National Surgical Adjuvant Breast and Bowel Project protocols of node-negative breast cancer.
PMID 19349544·J Clin Oncol·2009
2-rct
RIZ1 is potential CML tumor suppressor that is down-regulated during disease progression.
PMID 19602237·J Hematol Oncol·2009
8-other
A missense mutation in the Capza3 gene and disruption of F-actin organization in spermatids of repro32 infertile male mice.
PMID 19341723·Dev Biol·2009
7-preclinical
Role of trastuzumab in the adjuvant treatment of HER2-positive early breast cancer.
PMID 19245352·Womens Health (Lond)·2009
6-review
Lapatinib plus capecitabine versus capecitabine alone for HER2+ (ErbB2+) metastatic breast cancer: quality-of-life assessment.
PMID 19153829·Breast Cancer Res Treat·2009
3-trial
Phase I and pharmacokinetic study of cisplatin and troxacitabine administered intravenously every 28 days in patients with advanced solid malignancies.
PMID 19449006·Cancer Chemother Pharmacol·2009
3-trial
Gemcitabine/epirubicin/paclitaxel as neoadjuvant chemotherapy in locally advanced breast cancer: a phase II trial of the NSABP Foundation Research Group.
PMID 18650156·Clin Breast Cancer·2008
3-trial
A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.
PMID 18650162·Clin Breast Cancer·2008
2-rct
Identification and characterization of Rhox13, a novel X-linked mouse homeobox gene.
PMID 18675325·Gene·2008
7-preclinical
Q-TWiST analysis of lapatinib combined with capecitabine for the treatment of metastatic breast cancer.
PMID 18728660·Br J Cancer·2008
3-trial
The half century of clinical trials of the National Surgical Adjuvant Breast And Bowel Project.
PMID 18929150·Semin Oncol·2008
6-review
Safety of adjuvant endocrine therapy in postmenopausal women with breast cancer.
PMID 19060594·Am J Clin Oncol·2008
6-review
Benefit from exemestane as extended adjuvant therapy after 5 years of adjuvant tamoxifen: intention-to-treat analysis of the National Surgical Adjuvant Breast And Bowel Project B-33 trial.
PMID 18332472·J Clin Oncol·2008
4-observational
Unifying life-history analyses for inference of fitness and population growth.
PMID 18500940·Am Nat·2008
7-preclinical
The emerging role of lapatinib in HER2-positive breast cancer.
PMID 18366956·Curr Oncol Rep·2008
6-review
IIICS de novo glycosylated fibronectin as a marker for invasiveness in urothelial carcinoma of the urinary bladder (UBC).
PMID 18386055·J Cancer Res Clin Oncol·2008
8-other
HER-2 gene amplification, HER-2 and epidermal growth factor receptor mRNA and protein expression, and lapatinib efficacy in women with metastatic breast cancer.
PMID 19047115·Clin Cancer Res·2008
8-other
Neurokinin 1 receptor antagonism as a possible therapy for alcoholism.
PMID 18276852·Science·2008
2-rct
Cloning, expression, purification and crystallization of the PR domain of human retinoblastoma protein-binding zinc finger protein 1 (RIZ1).
PMID 19325838·Int J Mol Sci·2008
8-other
Preoperative chemotherapy: updates of National Surgical Adjuvant Breast and Bowel Project Protocols B-18 and B-27.
PMID 18258986·J Clin Oncol·2008
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 908 W 4TH NORTH ST
MORRISTOWN, TN 37814 - Phone
- (423) 522-4900
Quick Facts
- NPI
- 1528264223
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 37
- Publications
- 20
Are you this provider?
Claim Your Profile